Literature DB >> 8091257

Focal nodular hyperplasia of the liver.

K Bassel1, M Lee, N E Seymour.   

Abstract

The management of focal nodular hyperplasia (FNH) of the liver requires a systematic approach. After a histologic diagnosis of FNH is obtained, asymptomatic lesions can be observed safely with regular follow-up and treated if they become symptomatic or enlargement occurs. In the case presented here, we have elected follow-up with serial CT scans because our patient is asymptomatic and the lesion has not significantly enlarged. Patients who have symptomatic lesions while taking an oral contraceptive can have conservative follow-up when they stop taking the oral contraceptive, because regression of FNH has been reported to occur after cessation of oral contraceptive use. If the patient remains symptomatic or if the lesion enlarges after discontinuance of oral contraceptive use, surgical resection is warranted. Other symptomatic patients, including those with a previous history of taking oral contraceptives, should be treated by surgical resection or, when resection is not possible, by embolization or ligation of the hepatic artery, because symptomatic patients are at risk for having malignant lesions misdiagnosed as FNH.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8091257     DOI: 10.1097/00007611-199409000-00011

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  3 in total

1.  Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders.

Authors:  Z W Zhu; H Friess; L Wang; M Abou-Shady; A Zimmermann; A D Lander; M Korc; J Kleeff; M W Büchler
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

2.  Hepatocellular carcinoma in a patient with focal nodular hyperplasia.

Authors:  Craig M Coopersmith; Jeffrey A Lowell; Anjum Hassan; Todd K Howard
Journal:  HPB (Oxford)       Date:  2002       Impact factor: 3.647

3.  Massive hemorrhage and infarction complicating focal nodular hyperplasia of the liver.

Authors:  O F Bathe; C Mies; D Franceschi; J Casillas; A S Livingstone
Journal:  HPB (Oxford)       Date:  2003       Impact factor: 3.647

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.